Breast Cancer Drug Promising in Phase 3 Trial

An experimental drug could improve survival for women with breast cancer who have the BRCA1 and BRCA2 gene mutations, a new study says.

from WebMD Health https://ift.tt/2Mxabwn
via IFTTT